Business Wire · IBRX · November 9, 2026

ImmunityBio and Rafa Announce Israeli Ministry of Health Approval of ANKTIVA® Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ

Get the app for more

Explore stock news, insights and company research.